Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Free base crystal form of phenylpropanamide derivatives and preparation method thereof

A technology of crystal form and diffraction angle, which is applied in the preparation method of peptides, chemical instruments and methods, medical preparations containing active ingredients, etc., can solve problems such as poor fluidity, difficult filtration, and large hygroscopicity

Active Publication Date: 2021-07-02
JIANGSU HENGRUI MEDICINE CO LTD +1
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Generally speaking, amorphous pharmaceutical products often have other defects due to the lack of regular crystal structure, such as poor product stability, fine crystallization, difficult filtration, high hygroscopicity, easy caking, poor fluidity, etc. These defects often bring difficulties to practical mass production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Free base crystal form of phenylpropanamide derivatives and preparation method thereof
  • Free base crystal form of phenylpropanamide derivatives and preparation method thereof
  • Free base crystal form of phenylpropanamide derivatives and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] In the specification and claims of the present application, unless otherwise specified, the scientific and technical terms used herein have the meanings commonly understood by those skilled in the art. However, for a better understanding of the present invention, definitions and explanations of some related terms are provided below. In addition, when the definitions and explanations of terms provided in this application are inconsistent with the meanings commonly understood by those skilled in the art, the definitions and explanations of terms provided in this application shall prevail.

[0020] The "C1-6 alkyl" in the present invention means a linear or branched alkyl group containing 1-6 carbon atoms. Specific examples include but are not limited to: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, 2-methylbutyl, neopentyl, 1-ethylpropyl, n-hexyl, isohexyl, 3- Methylpentyl, 2-methylpentyl, 1-methylpentyl, 3,3-dimethyl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a free base crystal form of phenylpropanamide derivatives and a preparation method thereof. Specifically, the present invention relates to a new crystal form of the free base of phenylpropanamide derivatives, that is, crystal form I of the compound represented by formula (I). The present invention also relates to the preparation method of the I crystal form, the pharmaceutical composition and its use in the preparation of medicines for preventing and / or treating related diseases mediated by KOR agonists. The crystal form I of the compound of formula (I) obtained in the present invention has good stability and can be better used in clinical treatment.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry and relates to a chemical named (R)-N-((R)-6-amino-1-(4-(3-methylureido)piperidin-1-yl)-1-oxygen Hexan-2-yl)-2-((R)-2-((R)-2-amino-3-phenylpropanylamino)-3-phenylpropanylamino)-4-methylpentane The crystal form I of the amide compound, its preparation method, pharmaceutical composition and its use in the preparation of medicines for preventing and / or treating related diseases mediated by κ opioid receptor agonists. Background technique [0002] Opioid receptors are an important class of G protein-coupled receptors, and they are targets for the binding of endogenous opioid peptides and opioids. After activation, opioid receptors have a regulatory effect on the nervous system immunity and endocrine system. Opioids are Currently the strongest and commonly used central analgesic. Endogenous opioid peptides are opioid active substances naturally produced in mammals. The known endogenous opioid pepti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K5/107C07K1/02A61K38/07A61P29/00A61P17/04A61P7/10A61P3/12A61P1/00A61P11/14A61P27/06
CPCA61K38/00A61P1/00A61P3/12A61P7/10A61P11/14A61P17/04A61P27/06A61P29/00C07K5/1016
Inventor 张浩宇王林邵启云冯君贺峰
Owner JIANGSU HENGRUI MEDICINE CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products